Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 8/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.77 |
| ▸ | NSD2 | O96028 | 2/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.69 |
| ▸ | USP2 | O75604 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | APEX1 | P27695 | 1/20 | 0.64 |
| ▸ | METAP2 | P50579 | 1/20 | 0.63 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.63 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.63 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.63 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.58 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL29048907 | 0.94 | HPGD (0.68) | HPGDKDM4EALDH1A1NSD2HSD17B10 | |
| SCHEMBL1060622 | 0.89 | HPGD (0.71) | HPGDKDM4EALDH1A1NSD2HSD17B10 | |
| SCHEMBL6038030 | 0.87 | HPGD (0.73) | HPGDKDM4EALDH1A1NSD2HSD17B10 | |
| SCHEMBL28728994 | 0.87 | HPGD (0.73) | HPGDKDM4EALDH1A1NSD2HSD17B10 | |
| SCHEMBL4478849 | 0.87 | NSD2 (1.00) | HPGDKDM4EALDH1A1NSD2HSD17B10 | |
| SCHEMBL14727423 | 0.87 | ALDH1A1 (0.73) | HPGDKDM4EALDH1A1NSD2HSD17B10 | |
| SCHEMBL28901311 | 0.87 | ALDH1A1 (0.73) | HPGDKDM4EALDH1A1NSD2HSD17B10 | |
| SCHEMBL28730014 | 0.87 | HPGD (1.00) | HPGDKDM4EALDH1A1NSD2HSD17B10 | |
| SCHEMBL29433995 | 0.87 | HPGD (1.00) | HPGDKDM4EALDH1A1NSD2HSD17B10 | |
| SCHEMBL31680569 | 0.87 | KMT2A (0.89) | HPGDNSD2KMT2AUSP2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119661459-A | 1,2, 3-Benzotriazine-4 (3H) -one seleno compound and preparation method and application thereof | 赣南师范大学 | 2025-03-21 | — | — | CN | claimed |
| CN-118184588-A | N-aryl/alkyl quinazolinone compound and synthesis method thereof | 陕西科技大学 | 2024-06-14 | — | — | CN | claimed |
| EP-4608817-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-09-03 | — | — | EP | disclosed |
| CN-119661459-A | 1,2, 3-Benzotriazine-4 (3H) -one seleno compound and preparation method and application thereof | 赣南师范大学 | 2025-03-21 | — | — | CN | disclosed |
| CN-118184588-A | N-aryl/alkyl quinazolinone compound and synthesis method thereof | 陕西科技大学 | 2024-06-14 | — | — | CN | disclosed |
| WO-2024091450-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2024091450-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-05-02 | — | — | WO | disclosed |
| CN-114276203-B | Method for synthesizing 2-aminobenzamide compound by ultraviolet light induction | 湖南大学 | 2023-03-31 | — | — | CN | disclosed |
| CN-111646908-B | Method for preparing aromatic amine compound | 宜昌尚诺德生物医药科技有限公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-111732493-B | Synthesis process of arylamine compound | 宜昌尚诺德生物医药科技有限公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-114276203-A | Method for synthesizing 2-aminobenzamide compound by ultraviolet light induction | 湖南大学 | 2022-04-05 | — | — | CN | disclosed |
| CN-1017242-B | NEW QUIANZOLINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION | FUJISAWA PHARMACEUTICAL CO (JP) | 1992-07-01 | — | — | CN | disclosed |
| US-4883800-A | DIABETES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-11-28 | — | — | US | disclosed |
| EP-0145225-B1 | RECORD MATERIAL | The Wiggins Teape Group Limited (GB) | 1989-10-04 | — | — | EP | disclosed |
| US-4734419-A | Quinazoline derivatives, compositions thereof and their use in treating diabetic complications | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-03-29 | — | — | US | disclosed |
| CN-86106984-A | New quinazoline derivant and preparation method thereof | — | 1987-05-20 | — | — | CN | disclosed |
| EP-0218999-A2 | New quinazoline derivatives, process for their production and pharmaceutical compositions comprising them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-04-22 | — | — | EP | disclosed |
| US-4642322-A | Stabilization of chlorine-containing thermoplastics with nitrogen-containing organic compounds | CIBA-GEIGY CORPORATION (US) | 1987-02-10 | — | — | US | disclosed |
| US-4587538-A | Record material | THE WIGGINS TEAPE GROUP LIMITED (GB) | 1986-05-06 | — | — | US | disclosed |
| EP-0145225-A2 | Record material | The Wiggins Teape Group Limited (GB) | 1985-06-19 | — | — | EP | disclosed |